Drug
Tetrahydrobiopterin KG
Tetrahydrobiopterin KG: highest development phase Phase 1, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tetrahydrobiopterin 10 mg/kg NCT04800692 | Phase 1 | Claudication, Intermittent |
Latest
No recent events.
Follow Tetrahydrobiopterin KG on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.